Joseph P. Giuffrida
Joseph P. Giuffrida publishes mostly in Neurology, Rehabilitation and Cognitive Neuroscience, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Botulinum Toxin and Related Neurological Disorders.
- World rank
- #1,046,192 of 7,710,434 ranked researchers
- Rank in United States
- #340,122 of 1,627,098
- Works
- 29
- Citations
- 1.5k
- Citations per work
- 52.3
What does Joseph P. Giuffrida research?
Joseph P. Giuffrida's work is mostly in Medicine (85%), Neuroscience (4%), Engineering (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2587.3%
- Medicine2584.8%
- Health Professions12.5%
- Everything else26.4%
- Life Sciences13.8%
- Neuroscience13.8%
- Physical Sciences12.5%
- Engineering12.5%
- 1Neurology76% of their works
- 2Rehabilitation5% of their works
- 3Cognitive Neuroscience4% of their works
- 4Psychiatry and Mental health4% of their works
- 5Biomedical Engineering2% of their works
- 6Physical Therapy, Sports Therapy and Rehabilitation2% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
- Parkinson's Disease and Spinal Disorders
- Stroke Rehabilitation and Recovery
- Cerebral Palsy and Movement Disorders
- Autism Spectrum Disorder Research
- Muscle activation and electromyography studies
Which keywords describe Joseph P. Giuffrida's research?
The keywords of their largest research topics: Parkinson's Disease, Neurological Disorders, Deep Brain Stimulation, a-Synuclein, Neurodegeneration, Basal Ganglia, Subthalamic Nucleus and Botulinum Toxin.
- Muscle Fatigue
- Electromyography
- ICF Model
- Neural Plasticity
- Epidemiology
- Camptocormia
- Botulinum Toxin
- Basal Ganglia
- Neurodegeneration
- Neurological Disorders
- Parkinson's Disease
- Deep Brain Stimulation
- a-Synuclein
- Subthalamic Nucleus
- Neurotoxins
- Dropped Head Syndrome
- Motor Recovery
- Cerebral Palsy
- Autism Spectrum Disorders
- Genetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Parkinson's Disease503 topics
- Neurological Disorders383 topics
- Deep Brain Stimulation282 topics
- Neurodegeneration221 topic
- a-Synuclein221 topic
- Basal Ganglia211 topic
- Subthalamic Nucleus211 topic
- Botulinum Toxin101 topic
- Neurotoxins101 topic
- Camptocormia71 topic
- Dropped Head Syndrome71 topic
- Epidemiology52 topics
- Motor Recovery41 topic
- Neural Plasticity41 topic
- Cerebral Palsy31 topic
- ICF Model31 topic
- Autism Spectrum Disorders21 topic
- Electromyography21 topic
- Genetics21 topic
- Muscle Fatigue21 topic
Where does Joseph P. Giuffrida work?
Joseph P. Giuffrida's main affiliation in the publication record is Great Lakes NeuroTechnologies (United States), United States.
How many publications and citations does Joseph P. Giuffrida have?
OpenAlex counts 29 works and 1,517 citations for Joseph P. Giuffrida, an h-index of 18, ranking #1,046,192 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Joseph P. Giuffrida. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.